Synthetic lethality screens point the way to new cancer drug targets
Nature Reviews Drug Discovery 16, 589 (2017).
doi:10.1038/nrd.2017.165
Author: Asher Mullard
A resurgence in synthetic lethality screening, enabled by CRISPR gene editing, is unlocking targeted drugs for patients with cancerous loss-of-function mutations.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Asher Mullard Tags: News and Analysis Source Type: research